Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis
- 6 January 2020
- journal article
- research article
- Published by Elsevier BV in Cell Metabolism
- Vol. 31 (1), 174-+
- https://doi.org/10.1016/j.cmet.2019.10.012
Abstract
No abstract availableFunding Information
- National Cancer Institute (CA158301)
- Guangdong Innovative and Entrepreneurial Research Team Program (2016ZT06S638)
This publication has 69 references indexed in Scilit:
- Hypoxia-Inducible Factors: Mediators of Cancer Progression; Prognostic and Therapeutic Targets in Soft Tissue SarcomasCancers, 2013
- Effects of a glucokinase activator on hepatic intermediary metabolism: study with 13C-isotopomer-based metabolomicsBiochemical Journal, 2012
- Advances in sarcoma genomics and new therapeutic targetsNature Reviews Cancer, 2011
- Mitochondrial Subversion in CancerCancer Prevention Research, 2011
- Expression Profiling of Liposarcoma Yields a Multigene Predictor of Patient Outcome and Identifies Genes That Contribute to LiposarcomagenesisCancer Research, 2011
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyNature Genetics, 2010
- Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous HistiocytomaPLOS ONE, 2009
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal TumorsClinical Cancer Research, 2008
- On the Origin of Cancer CellsScience, 1956